Show simple item record

dc.contributor.authorImai, Shin-ichiro
dc.contributor.authorGuarente, Leonard Pershing
dc.date.accessioned2017-01-12T19:04:28Z
dc.date.available2017-01-12T19:04:28Z
dc.date.issued2010-03
dc.identifier.issn0165-6147
dc.identifier.urihttp://hdl.handle.net/1721.1/106460
dc.description.abstractSince the discovery of NAD-dependent deacetylase activity of the silent information regulator-2 (SIR2) family (‘sirtuins’), many exciting connections between protein deacetylation and energy metabolism have been revealed. The importance of sirtuins in the regulation of many fundamental biological responses to various nutritional and environmental stimuli has been firmly established. Sirtuins have also emerged as critical regulators for aging and longevity in model organisms. Their absolute requirement of NAD has revived an enthusiasm in the study of mammalian biosynthesis of NAD. Sirtuin-targeted pharmaceutical and nutriceutical interventions against age-associated diseases are also on the horizon. This review summarizes the recent progress in sirtuin research (particularly in mammalian sirtuin biology) and re-evaluates the connection between sirtuins, metabolism, and age-associated diseases (e.g., type-2 diabetes) to set a basis for the next ten years of sirtuin research.en_US
dc.description.sponsorshipPaul F. Glenn Foundationen_US
dc.description.sponsorshipNational Institutes of Health (U.S.)en_US
dc.description.sponsorshipAmerican Asthma Foundationen_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.tips.2010.02.003en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleTen years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseasesen_US
dc.typeArticleen_US
dc.identifier.citationImai, Shin-ichiro, and Leonard Guarente. “Ten Years of NAD-Dependent SIR2 Family Deacetylases: Implications for Metabolic Diseases.” Trends in Pharmacological Sciences 31.5 (2010): 212–220.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorGuarente, Leonard Pershing
dc.relation.journalTrends in Pharmacological Sciencesen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsImai, Shin-ichiro; Guarente, Leonarden_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-4064-2510
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record